Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acacia catechu seed extract is a botanical extract derived from the seeds of the *Acacia catechu* Willd. tree (family Fabaceae), commonly known as black cutch or catechu. Traditionally used in Ayurvedic medicine, the extract contains bioactive phytochemicals such as epicatechin, rutin, quercetin, and catechin. Preclinical studies have demonstrated its cytotoxic and pro-apoptotic activity against various cancer cell lines, including human hepatocellular carcinoma (HepG2) and oral squamous carcinoma (SCC-25). The extract's mechanism of action involves the induction of oxidative stress via reactive oxygen species (ROS) generation and the subsequent activation of the mitochondrial apoptotic pathway, characterized by the upregulation of Bax, cytochrome c, and caspases-3 and 9, and the downregulation of Bcl-2. Additionally, it exhibits hepatoprotective, anti-inflammatory, antioxidant, antidiabetic, and antimicrobial properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acacia catechu seed extract.